TOPOTECAN for Undifferentiated sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 35 adverse event reports in the FDA FAERS database where TOPOTECAN was used for Undifferentiated sarcoma.
Most Reported Side Effects for TOPOTECAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 425 | 12.0% | 21 | 330 |
| Off label use | 390 | 11.0% | 88 | 72 |
| Death | 332 | 9.4% | 331 | 17 |
| Product use in unapproved indication | 323 | 9.1% | 36 | 40 |
| Neutropenia | 255 | 7.2% | 34 | 147 |
| Pyrexia | 252 | 7.1% | 23 | 222 |
| Anaemia | 242 | 6.8% | 35 | 125 |
| Malignant neoplasm progression | 238 | 6.7% | 61 | 26 |
| Drug ineffective | 216 | 6.1% | 56 | 30 |
| Disease progression | 207 | 5.9% | 77 | 30 |
| Thrombocytopenia | 207 | 5.9% | 39 | 79 |
| Vomiting | 206 | 5.8% | 16 | 135 |
| Pancytopenia | 177 | 5.0% | 32 | 99 |
| Diarrhoea | 168 | 4.8% | 13 | 111 |
| Nausea | 163 | 4.6% | 19 | 70 |
Other Indications for TOPOTECAN
Neuroblastoma (443)
Product used for unknown indication (350)
Retinoblastoma (302)
Lung neoplasm malignant (177)
Small cell lung cancer (158)
Ovarian cancer (155)
Refractory cancer (141)
Recurrent cancer (114)
Neoplasm malignant (86)
Congenital retinoblastoma (83)
Other Drugs Used for Undifferentiated sarcoma
DOXORUBICIN (106)
IFOSFAMIDE (84)
CYCLOPHOSPHAMIDE (64)
VINCRISTINE (57)
PAZOPANIB (52)
ETOPOSIDE (50)
GEMCITABINE (31)
OLARATUMAB (27)
DOCETAXEL (26)
PEMBROLIZUMAB (25)